Sun Pharma Secures Ratings Boost From Moody’s, S&P on $11.75-Billion Organon Acquisition Bid. This item is based on reporting by Free Press Journal, published September 8, 2026. We have not reproduced that reporting here — follow the source link above for the full story. Mumbai, India coverage on this site summarises and credits the outlets that do the original reporting.